文献速递关节外科创伤骨科

慢性髋膝关节假体周围感染两阶段翻修术的实际成功率

Current actual success rate of the two-stage exchange arthroplasty strategy in chronic hip and knee periprosthetic joint infection.
PubMed 文献 · Bone Joint J · 2020-01-01

本研究回顾性纳入162例慢性髋或膝关节假体周围感染患者,均接受两阶段翻修术,平均随访57.3个月。若仅计算完成再植入者,成功率为80.6%;但纳入未再植入者后成功率降至71.6%,提示排除未再植入患者会高估成功率约9%。

要点

  • 未再植入者占11.1%,原因包括内科问题、患者选择和死亡。
  • 仅计再植入者成功率80.6%,计入未再植入者后降至71.6%。
  • 高龄、ASA≥III级、McPherson C宿主和革兰阴性感染是间隔器保留的独立危险因素。

核心结论

  • 两阶段翻修术的实际成功率可能低于既往报告,排除未再植入患者会导致成功率被高估约9%。

研究设计与样本

  • 回顾性队列研究,纳入2010年1月至2018年10月期间接受两阶段翻修术的慢性髋或膝关节假体周围感染患者,最少随访一年,共162例。

主要发现

  • 平均随访57.3个月(范围12.1至115.7个月),18例(11.1%)未进行再植入。
  • 仅考虑再植入患者时成功率为80.6%,纳入未再植入患者后成功率降至71.6%。
  • 未再植入组死亡率更高。

关键数值与推荐

  • 主要终点为感染根除;未再植入原因包括内科问题(10例)、患者选择(4例)和死亡(4例)。
  • 高龄、美国麻醉医师协会(ASA)分级≥III级、McPherson C宿主和革兰阴性相关假体周围感染是间隔器保留的独立危险因素。

临床怎么用

  • 评估两阶段翻修术成功率时应纳入未再植入患者,以避免高估疗效。
  • 对存在高龄、ASA≥III级、McPherson C宿主或革兰阴性感染等危险因素的患者,应积极优化内科状况以提高再植入率和成功率并降低死亡率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The success rates of two-stage revision arthroplasty for infection have evolved since their early description. The implementation of internationally accepted outcome criteria led to the readjustment of such rates. However, patients who do not undergo reimplantation are usually set aside from these calculations. The aim of this study was to investigate the outcomes of two-stage revision arthroplasty when considering those who do not undergo reimplantation, and to investigate the characteristics of this subgroup. METHODS: A retrospective cohort study was conducted. Patients with chronic hip or knee periprosthetic joint infection (PJI) treated with two-stage revision between January 2010 and October 2018, with a minimum follow-up of one year, were included. Variables including demography, morbidity, microbiology, and outcome were collected. The primary endpoint was the eradication of infection. Patients who did not undergo reimplantation were analyzed in order to characterize this subgroup better. RESULTS: A total of 162 chronic PJIs were included in the study. After a mean follow-up of 57.3 months (12.1 to 115.7), 18 patients (11.1%) did not undergo reimplantation, due either to medical issues (10), the patient's choice (4), or death (4). When only considering those who underwent reimplantation, the success rate was 80.6%. However, when those who did not undergo reimplantation were included, the success rate dropped to 71.6%. Advanced age, American Society of Anesthesiologists grade ≥ III, McPherson's C host, and Gram-negative related PJI were independent risk factors for retention of the spacer. The mortality was higher in the non-reimplanted group. CONCLUSION: The real success rate of two-stage revision may not be as high as previously reported. The exclusion of patients who do not undergo reimplantation resulted in a 9% overestimation of the success rate in this series. Many comorbidity-related risk factors for retention of the spacer were identified, as well as higher death rates in this group. Efforts should be made to optimize these patients medically in order to increase reimplantation and success rates, while decreasing mortality. Cite this article: Bone Joint J 2020;102-B(12):1682-1688.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Corona PS, Vicente M, Carrera L, et al. Current actual success rate of the two-stage exchange arthroplasty strategy in chronic hip and knee periprosthetic joint infection. Bone Joint J. 2020. PMID: 33249903. doi:10.1302/0301-620X.102B12.BJJ-2020-0792.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。